Home/Filings/4/0001209191-22-004758
4//SEC Filing

Cooper Simon Peter 4

Accession 0001209191-22-004758

CIK 0001664710other

Filed

Jan 24, 7:00 PM ET

Accepted

Jan 25, 4:12 PM ET

Size

5.7 KB

Accession

0001209191-22-004758

Insider Transaction Report

Form 4
Period: 2022-01-21
Cooper Simon Peter
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2022-01-21+50,00050,000 total
    Exercise: $46.30Exp: 2032-01-20Common Stock (50,000 underlying)
Footnotes (1)
  • [F1]One-fourth (1/4th) of the shares subject to the option shall vest on January 19, 2023, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Issuer

Keros Therapeutics, Inc.

CIK 0001664710

Entity typeother

Related Parties

1
  • filerCIK 0001877225

Filing Metadata

Form type
4
Filed
Jan 24, 7:00 PM ET
Accepted
Jan 25, 4:12 PM ET
Size
5.7 KB